Drug intelligence / Profile preview

sodium hyaluronate (SIFI SpA)

Development stage
Unknown
Lead developer
SIFI
Administration
Ophthalmic
01

Overview

Eyestil is a brand of ophthalmic solutions developed by SIFI SpA, primarily containing sodium hyaluronate (hyaluronic acid) for the treatment of dry eye disease and ocular surface discomfort. Sodium hyaluronate is a naturally occurring polysaccharide with high viscoelasticity and water-binding capacity, which allows it to stabilize the tear film and provide long-lasting lubrication to the corneal and conjunctival epithelium. The product line includes preservative-free formulations (Eyestil PF) and a combination product, Eyestil SYNFO, which incorporates xanthan gum to further enhance the residence time of the solution on the eye. Eyestil is regulated as a medical device in many regions, functioning as an artificial tear to alleviate symptoms such as burning, irritation, and foreign body sensation.

Brand names
EyestilEyestil SYNFOEyestil PF
Other names
sodium hyaluronatehyaluronic acid

Beyond the preview

Go deeper on sodium hyaluronate (SIFI SpA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium hyaluronate (SIFI SpA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call